Ebglyss for Atopic Dermatitis One of the latest treatments for atopic dermatitis is Ebglyss (lebrikizumab), a targeted biologic therapy for moderate-to-severe atopic dermatitis. Understanding Atopic Dermatitis Atopic dermatitis (AD), commonly known as eczema, is a chronic inflammatory skin condition characterized by intense itching, redness, and skin barrier disruption. It affects millions of individuals worldwide and… Read More
Adbry for Atopic Dermatitis
Adbry is the brand name for tralokinumab-ldrm. It is approved for the treatment of atopic dermatitis, commonly referred to as eczema, a chronic skin condition characterized by itching, redness, and inflammation. Adbry is approved for those with moderate-to-severe atopic dermatitis who have not responded well to other treatments. Tralokinumab is a monoclonal antibody, a type… Read More
